Therefore, in the context of cancer, inhibiting the “normal” HSP90 function is beneficial; however, the consequent activation of the HSF1‐mediated transcriptional response feeds these oncogenic protein helpers (i.e., HSP90 and HSP70) into the same system. This evidence concerns the gene HSF1 and cancer.